Christopher Ing, PhDChief Science Officer at ProteinQuireSpeaker
Profile
Chris is the co-founder and CSO of ProteinQure, a biotechnology company focused on the development of next-generation protein-based therapeutics. He received a PhD in Biochemistry at the University of Toronto focusing on structural biology and biophysics of ion channels, enzymes, and membrane receptors. Previously, he studied Theoretical Chemistry and Computational Physics at the University of Waterloo. He currently leads computational chemistry methods development and applications at ProteinQure, based in Toronto, Canada. He is passionate about cross-disciplinary collaboration to design novel synthetic protein libraries, new protein modalities, and better data-driven strategies for rational drug design.
Agenda Sessions
Code to First-in-Human: AI-Designed Peptide Drug Conjugates with Efficacy in Preclinical Models of Breast Cancer
, 17:00View Session
